DV
Dividend Vision

VTVT — vTv Therapeutics Inc

vTv Therapeutics Inc (VTVT)

Total return is -93.1% over the past 11 years, 434.8 points behind SPY at 341.7%. Its deepest 1-year drawdown was 32.1%.

VTVT is an equity stock focused on vTv Therapeutics Inc, a biotechnology company. As a single-stock holding rather than a diversified fund, it does not have a traditional dividend distribution rate or expense ratio typical of ETFs. This holding appeals primarily to investors with conviction in the company's pipeline and commercial prospects rather than those seeking regular dividend income or broad diversification.

VTVT key facts

Asset type
Stock
Asset class
Equity
Inception date
07/30/2015
Last close
$30.12
Market cap
$127,533,624
Average volume
74800.0
Beta
0.252
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.78